PF-05280602
B3051001
Phase 1 mab completed
Quick answer
PF-05280602 for Hemophilia A is a Phase 1 program (mab) at CATALYST PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- CATALYST PHARMACEUTICALS, INC.
- Indication
- Hemophilia A
- Phase
- Phase 1
- Modality
- mab
- Status
- completed